In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...